港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

勁方醫藥-B

28.020

-1.740-5.85%

成交量：104.16萬

成交額：2,988.49萬

市值：103.67億

市盈率：-14.18

高：31.180

開：30.360

低：27.540

收：29.760

52周最高：50.200

52周最低：24.320

股本：3.70億

香港流通股本：3.38億

量比：0.71

換手率：0.31%

股息：- -

股息率：- -

每股收益(LYR):-1.976

淨資產收益率：--

總資產收益率：-30.27%

市淨率：-3.59

市盈率(LYR):-14.18

市銷率: 49.08

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

勁方醫藥-B10月23日主力淨流入174.2萬元散户資金拋售

港股異動 | 勁方醫藥-B(02595)由跌轉漲逾9% GFH375聯合療法治療晚期實體瘤研究完成首例入組

智通财经网

勁方醫藥-B(02595)：KRAS G12D抑制劑GFH375聯合西妥昔單抗或化療治療晚期實體瘤的Ib/II期研究完成首例患者給藥

勁方醫藥-B(02595)10月21日因超額配股權獲行使而發行1338.6萬股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/02595"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"勁方醫藥-B","latestPrice":28.02,"timestamp":1761293120109,"preClose":29.76,"halted":0,"volume":1041600,"delay":0,"floatShares":338000000,"shares":370000000,"eps":-1.976,"marketStatus":"未開盤","change":-1.74,"latestTime":"10-24 16:05:20","open":30.36,"high":31.18,"low":27.54,"amount":29884900,"amplitude":0.122312,"askPrice":28,"askSize":13800,"bidPrice":27.98,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761528600000},"marketStatusCode":0,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":29.76,"openAndCloseTimeList":[[1761269400000,1761278400000],[1761282000000,1761292800000]],"volumeRatio":0.706046950538445,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":338000000,"roa":"-30.27%","roe":"--","lyrEps":-1.976,"volumeRatio":0.706046950538445,"shares":370000000,"dividePrice":0,"high":31.18,"amplitude":0.122312,"preClose":29.76,"low":27.54,"week52Low":24.32,"pbRate":"-3.59","psRate":"49.08","week52High":50.2,"institutionHeld":0,"latestPrice":28.02,"committee":-0.971429,"eps":-1.976,"divideRate":0,"volume":1041600,"delay":0,"ttmEps":-2.744,"open":30.36,"prevYearClose":20.39,"prevWeekClose":31.8,"prevMonthClose":40,"prevQuarterClose":40,"fiveDayClose":31.8,"twentyDayClose":40.64,"sixtyDayClose":20.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2025-10-24","current":-10.21137,"percent":0.956522,"low":-19.62221,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"high":-9.058573,"avg":-14.513639,"sd":4.050774,"marketCap":9676444452},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452}],"updateTime":1761495137035},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2577584296","title":"勁方醫藥-B10月23日主力淨流入174.2萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2577584296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577584296?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 16:15","pubTimestamp":1761207342,"startTime":"0","endTime":"0","summary":"10月23日, 劲方医药-B股价涨12.22%，报收29.76元，成交金额5535.3万元，换手率0.62%，振幅25.19%，量比1.33。劲方医药-B今日主力资金净流入174.2万元，上一交易日主力净流出114.1万元。该股近5个交易日下跌3.85%，主力资金累计净流出541.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1242.8万元，其中净流出天数为12日。该股主力净额占比0.02%，港股市场排名271/2682。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023161930a47030d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023161930a47030d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","02595","BK1515","BK1574"],"gpt_icon":0},{"id":"2577789573","title":"港股異動 | 勁方醫藥-B(02595)由跌轉漲逾9% GFH375聯合療法治療晚期實體瘤研究完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2577789573","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577789573?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 15:17","pubTimestamp":1761203842,"startTime":"0","endTime":"0","summary":"消息面上，劲方医药宣布，旗下口服高活性及高选择性小分子KRAS G12D抑制剂GFH375，联合疗法用于治疗KRAS G12D突变型晚期实体瘤的Ib/II期研究，首例患者已在北京大学肿瘤医院完成入组。该项研究今年9月获得国家药监局临床试验批准，涉及联合西妥昔单抗或化疗两项联合疗法，其中GFH375联合化疗方案为一线胰腺导管腺癌治疗方案。报告聚焦该试验600 mgQD剂量组PDAC患者的研究数据，显示GFH375治疗PDAC患者的疗效突出且安全性可控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK1515","159938","09939","BK1161","02595"],"gpt_icon":0},{"id":"2577198386","title":"勁方醫藥-B(02595)：KRAS G12D抑制劑GFH375聯合西妥昔單抗或化療治療晚期實體瘤的Ib/II期研究完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2577198386","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577198386?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 07:34","pubTimestamp":1761089667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B 发布公告，GFH375联合疗法治疗KRAS G12D突变型晚期实体瘤的Ib/II期研究首例患者在北京大学肿瘤医院完成入组。Ib期试验将首先在北京大学肿瘤医院等约15家中心开展，整体试验的主要研究目的为评估GFH375联合西妥昔单抗或化疗两项联合疗法在实体瘤患者中的安全性╱耐受性、疗效和药代动力学特征。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","09939","BK1161","02595","BK1515"],"gpt_icon":1},{"id":"2577847319","title":"勁方醫藥-B(02595)10月21日因超額配股權獲行使而發行1338.6萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577847319","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577847319?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 16:33","pubTimestamp":1761035615,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2025年10月21日因超额配股权获悉数行使而发行及配发1338.6万股H股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1515","BK1574","02595","159938","BK1161"],"gpt_icon":0}],"pageSize":4,"totalPage":16,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02595\",params:#limit:6,delay:false,,,undefined,":[]}}